Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...
Glimmers of a resurgence in biotech IPO activity in 2026 have continued with the news that two more companies – Belgium's AgomAb Therapeutics and SpyGlass Pharma of the US – are sizing up investor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results